» Articles » PMID: 31226552

Salt Bridge-forming Residues Positioned over Viral Peptides Presented by MHC Class I Impacts T-cell Recognition in a Binding-dependent Manner

Overview
Journal Mol Immunol
Date 2019 Jun 22
PMID 31226552
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

The viral peptides presentation by major histocompatibility complex class I (MHC I) molecules play a pivotal role in T-cell recognition and the subsequent virus clearance. This process is delicately adjusted by the variant residues of MHC I, especially the residues in the peptide binding groove (PBG). In a series of MHC I molecules, a salt bridge is formed above the N-terminus of the peptides. However, the potential impact of the salt bridge on peptide binding and T-cell receptor (TCR) recognition of MHC I, as well as the corresponding molecular basis, are still largely unknown. Herein, we determined the structures of HLA-B*4001 and H-2K in which two different types of salt bridges (Arg62-Glu163 or Arg66-Glu163) across the PBG were observed. Although the two salt bridges led to different conformation shifts of both the MHC I α helix and the peptides, binding of the peptides with the salt bridge residues was relatively conserved. Furthermore, through a series of in vitro and in vivo investigations, we found that MHC I mutations that disrupt the salt bridge alleviate peptide binding and can weaken the TCR recognition of MHC I-peptide complexes. Our study may provide key references for understanding MHC I-restricted peptide recognition by T-cells.

Citing Articles

T cell immune evasion by SARS-CoV-2 JN.1 escapees targeting two cytotoxic T cell epitope hotspots.

Tian J, Shang B, Zhang J, Guo Y, Li M, Hu Y Nat Immunol. 2025; 26(2):265-278.

PMID: 39875585 DOI: 10.1038/s41590-024-02051-0.


Seeing the T cell Immunity of SARS-CoV-2 and SARS-CoV: Believing the Epitope-Oriented Vaccines.

Yue C, Wang P, Tian J, Gao G, Liu K, Liu W Int J Biol Sci. 2023; 19(13):4052-4060.

PMID: 37705735 PMC: 10496500. DOI: 10.7150/ijbs.80468.


Charge-based interactions through peptide position 4 drive diversity of antigen presentation by human leukocyte antigen class I molecules.

Jackson K, Antunes D, Talukder A, Maleki A, Amagai K, Salmon A PNAS Nexus. 2022; 1(3):pgac124.

PMID: 36003074 PMC: 9391200. DOI: 10.1093/pnasnexus/pgac124.


Recent Advancements in Nanomedicine for 'Cold' Tumor Immunotherapy.

Chen Q, Sun T, Jiang C Nanomicro Lett. 2021; 13(1):92.

PMID: 34138315 PMC: 8006526. DOI: 10.1007/s40820-021-00622-6.


Immunoinformatics-aided identification of T cell and B cell epitopes in the surface glycoprotein of 2019-nCoV.

Baruah V, Bose S J Med Virol. 2020; 92(5):495-500.

PMID: 32022276 PMC: 7166505. DOI: 10.1002/jmv.25698.

References
1.
Liu J, Qian X, Chen Z, Xu X, Gao F, Zhang S . Crystal structure of cell adhesion molecule nectin-2/CD112 and its binding to immune receptor DNAM-1/CD226. J Immunol. 2012; 188(11):5511-20. DOI: 10.4049/jimmunol.1200324. View

2.
Zhang Y, Zhang H, Ma W, Liu K, Zhao M, Zhao Y . Evaluation of Zika Virus-specific T-cell Responses in Immunoprivileged Organs of Infected Ifnar1-/- Mice. J Vis Exp. 2018; (140). PMC: 6235543. DOI: 10.3791/58110. View

3.
Tynan F, Reid H, Kjer-Nielsen L, Miles J, Wilce M, Kostenko L . A T cell receptor flattens a bulged antigenic peptide presented by a major histocompatibility complex class I molecule. Nat Immunol. 2007; 8(3):268-76. DOI: 10.1038/ni1432. View

4.
Chan K, Gully B, Gras S, Beringer D, Kjer-Nielsen L, Cebon J . Divergent T-cell receptor recognition modes of a HLA-I restricted extended tumour-associated peptide. Nat Commun. 2018; 9(1):1026. PMC: 5847591. DOI: 10.1038/s41467-018-03321-w. View

5.
Hulsmeyer M, Fiorillo M, Bettosini F, Sorrentino R, Saenger W, Ziegler A . Dual, HLA-B27 subtype-dependent conformation of a self-peptide. J Exp Med. 2004; 199(2):271-81. PMC: 2211767. DOI: 10.1084/jem.20031690. View